NSPR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
InspireMD Inc (NSPR) is not a strong buy at this moment for a beginner investor with a long-term strategy. The technical indicators show bearish trends, and there are no significant positive catalysts or trading signals supporting an immediate entry. While the company has shown improvement in financial performance, the lack of recent news, weak trading sentiment, and no strong analyst momentum make it prudent to hold off on buying for now.
The technical indicators suggest a bearish trend. The MACD histogram is negative and expanding downward, RSI is neutral at 32.537, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 1.743, with support at 1.628 and resistance at 1.858.
The company's financials for Q3 2025 show strong YoY growth in revenue (+39.39%), net income improvement (+61.06%), and gross margin increase (+49.72%). Analysts have initiated coverage with a Buy rating and a $6 price target, indicating long-term potential.
Technical indicators are bearish, and there is no recent news or significant trading activity from insiders, hedge funds, or Congress. The stock has a high implied volatility, which may deter beginner investors. No Intellectia Proprietary Trading Signals are present.
In Q3 2025, InspireMD reported revenue growth of 39.39% YoY to $2,523,000. Net income improved by 61.06% YoY to -$12,708,000, and EPS increased by 6.25% YoY to -0.17. Gross margin improved significantly to 34.24%, up 49.72% YoY.
Maxim initiated coverage on InspireMD with a Buy rating and a $6 price target on 2026-02-02. This indicates optimism for long-term growth, but there is no recent momentum or updates from other analysts.
